Related Experiment Video
Updated: Jun 24, 2026

Static Adhesion Assay for the Study of Integrin Activation in T Lymphocytes
Published on: June 13, 2014
[Effect of activation of nuclear factor-KappaB on modulation of secretion of intercellular adhesion molecule-1 by
Pin-hu Liao1, Xue-ke Du, Bing Huang
1Coronary Care Unit, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi, China. liaopinhu@gmail.com
Insights
Interleukin-1beta (IL-1beta) upregulates intercellular adhesion molecule-1 (ICAM-1) in A549 cells by activating the nuclear factor-KappaB (NF-KappaB) pathway. Inhibition of this pathway blocks IL-1beta-induced ICAM-1 expression, demonstrating NF-KappaB
Area of Science:
- Cellular and Molecular Biology
- Immunology
- Biochemistry
Context:
- Intercellular adhesion molecule-1 (ICAM-1) plays a crucial role in inflammatory responses and immune cell trafficking.
- Interleukin-1beta (IL-1beta) is a key pro-inflammatory cytokine implicated in various diseases.
- Understanding the regulatory mechanisms of ICAM-1 expression is vital for developing targeted therapies.
Purpose:
- To elucidate the role of IL-1beta in regulating ICAM-1 expression on A549 lung carcinoma cells.
- To investigate the specific intracellular signaling pathways, particularly the nuclear factor-KappaB (NF-KappaB) pathway, involved in IL-1beta-mediated ICAM-1 induction.
- To assess the impact of NF-KappaB inhibition on IL-1beta-induced ICAM-1 expression.
Summary:
- Interleukin-1beta (IL-1beta) stimulation of A549 cells leads to the activation of the nuclear factor-KappaB (NF-KappaB) signaling cascade, evidenced by increased phosphorylation and degradation of IkappaBalpha, and subsequent nuclear translocation of the p65 subunit.
- IL-1beta significantly enhances the DNA binding activity of NF-KappaB p65 to the ICAM-1 promoter, leading to increased ICAM-1 mRNA and protein expression.
- Pharmacological inhibition of IkappaB kinase-2 (IKK-2) with SC-514 effectively blocks IL-1beta-induced NF-KappaB activation, p65 nuclear translocation, and downstream ICAM-1 expression, confirming the central role of this pathway.
Impact:
- This study establishes a clear link between IL-1beta, NF-KappaB activation, and ICAM-1 upregulation in A549 cells.
- The findings highlight the NF-KappaB pathway as a critical mediator of IL-1beta's pro-inflammatory effects on adhesion molecule expression.
- These results provide a molecular basis for targeting the NF-KappaB pathway to modulate ICAM-1-dependent inflammatory processes in lung diseases.
Objective:
To investigate the effects of interleukin-1beta (IL-1beta) on intercellular adhesion molecule-1 (ICAM-1) expression on A549 cell and underlying signal transduction pathways.
Methods:
A549 cells were pre-incubated with SC-514 [nuclear factor-KappaB (NF-KappaB) inhibitor (IKappaB) kinase-2 (IKK-2) inhibitor] and/or pre-treated with 1 microg/L IL-1beta. The phosphorylated IKappaBalpha (pIKappaBalpha) and degradation of IKappaBalpha were determined by Western blotting with specific antibody at 5, 10, 30 and 60 minutes. Laser scanning confocal microscope (LSCM) was used to examine the nuclear translocation of p65 at 30 minutes after stimulation. The DNA binding activity of p65 in nuclear extracts was detected at 1 hour following IL-1beta treatment. Chromatin immunoprecipitation (ChIP) assays combined with polymerase chain reaction (PCR) were used to evaluate interaction between p65 and ICAM-1 promoter site DNA at 1 hour after stimulation. The expression of ICAM-1 mRNA was assessed by reverse transcription (RT)-PCR at 4 hours, and the ICAM-1 expression on A549 cell surface was measured by enzyme linked immunosorbent assay (ELISA) at 24 hours after IL-1beta was added.
Results:
IL-1beta induced rapid pIKappaBalpha augmentation and its subsequent degradation. LSCM graphs showed that IL-1beta stimulated the translocation of p65 from the cytosol to the nucleus. IL-1beta significantly increased the DNA binding ability of p65 (P<0.01) in cell nuclear extracts. ChIP-PCR suggested that both acetylated histone 4 and p65 were recruited to ICAM-1 promoter. IL-1beta significantly augmented ICAM-1 mRNA level at 4 hours and expression of ICAM-1 on A549 cell surface at 24 hours (both P<0.01). The IKK-2 inhibitor, SC-514, inhibited IL-1beta induced IKappaBalpha protein activity, blocked p65 nuclear translocation, caused a significant reduction in IL-1beta induced DNA binding activity for p65 and ICAM-1 mRNA expression, and suppressed ICAM-1 expression on A549 cell surface (all P<0.01).
Conclusion:
These results suggest that the activation of NF-KappaB mediates IL-1beta induced ICAM-1 expression in A549 cells.
More Related Videos
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...
Adherens Junctions
Adherens Junctions are Dynamic
The endothelial cells...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Overview of Cell-Matrix Interactions

